24-hour MII / pH monitoring is an effective tool with the diagnosis of neonatal gastroesophageal reflux disease

24-hour MII / pH monitoring is an effective tool with the diagnosis of neonatal gastroesophageal reflux disease - 24-hour MII / pH monitoring is an effective tool with the diagnosis of neonatal gastroesophageal reflux disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037413

Enrollment

100

Registered

2019-07-18

Start date

2019-07-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal gastroesophageal reflux disease

Interventions

We can diagnose neonatal gastroesophageal reflux disease and can intervene for assessment of severity.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The symptoms of gastroesophageal reflux disease such as bradycardia, hypoxia, vomiting, and poor weight gain is eligible.

Exclusion criteria

Exclusion criteria: Those who the doctor deems inappropriate or those who do not get consent is excluded.

Design outcomes

Primary

Measure	Time frame
pH index, total number of regurgitation and presence or absence of gastroesophageal reflux in contrast examination	—

Countries

Japan

Contacts

Public ContactMayumi Arakaki

University of Ryukyus, Hospital Department of Pediatrics

h133648@med.u-ryukyu.ac.jp098-895-3331

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026